No Prescription |
 |
 | ||
|
Betnovate C Lotion Diprosone |
|
| ||
No Prescription » Prescription Drugs 3 » Betnovate C Lotion Diprosone BETNOVATE is used to treat various inflammatory skin conditions including eczema psoriasis and dermatitis.BETNOVATE belongs to a group of medicines known as corticosteroids frequently called 'steroids'. They are not 'anabolic steroids' which are the steroids sometimes misused by athletes.BETNOVATE works by reducing the inflammation in the affected area to reduce the redness and itchiness of the skin.Do not use if:You must not use BETNOVATE if:#you have ever had an allergic reaction to Betamethasone Valerate 'BetaÖ' 'BivateÖ' or any of the ingredients listed toward the end of this leaflet. (See "Ingredients") #you have acne or rosacea (severe flushing of the skin on and around the nose) #you have chickenpox #you have cold sores or genital herpes (herpes simplex virus) the irritated area of skin is also infected. the expiry date (EXP) printed on the pack has passed. the packaging is torn or shows signs of tampering #Do not use BETNOVATE to treat dermatitis or other skin irritations around your mouth genitals or anus unless specifically told to do so by your doctor.Do not let BETNOVATE lotion get in your eyes.Tell your doctor if:You must tell your doctor if:#you are allergic to foods dyes preservatives or any other medicines. #you are taking any other medicines including medicines #you buy without a prescription. #you are breastfeeding pregnant or trying to become pregnant. Buy Betnovate C Lotion Diprosone and other Prescription Drugs 3 products online at Medstore. Buy Online at Medstore - Click Here!
About Betnovate C Lotion Diprosone: Product Type: Prescription Drugs 3 Betnovate-C Lotion( Diprosone Generic Betamethasone ) Betnovate-C Lotion (Diprosone Generic Betamethasone) Diprosone Generic Betamethasone 0.1% w/w 50mL 150mL(3 x 50mL) Diprosone Generic Betamethasone Betnovate-C Lotion
View more Prescription Drugs 3 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
